Market Overview:
The global TNF & IL Cytokines market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of cancer and malignancy, arthritis, asthma / airway inflammation, and other diseases. Additionally, the increasing demand for TNF & IL Cytokines for research and development purposes is also contributing to the growth of this market. However, factors such as high costs associated with R&D activities and stringent regulatory approvals are restraining the growth of this market. On the basis of type, TNF accounted for a major share of the global TNF & IL Cytokines market in 2017. This segment is expected to grow at a CAGR of 7% during the forecast period from 2018 to 2030 due to rising demand for these cytokines for therapeutic applications across various disease indications. On the basis of application, cancer and malignancy was a leading segment in 2017 owing to rising incidence rates globally coupled with growing awareness about available treatment options among patients suffering from cancer or any other malignant diseases.
Product Definition:
Cytokines are proteins that help regulate the immune system and inflammation. Tumor necrosis factor (TNF) is a cytokine that helps to destroy cancer cells. Interleukin (IL) is a cytokine that helps to activate the immune system and fight infection.
TNF:
The cytokine storm is a term used to define the abnormal response of cells within the immune system that result from an overreaction to normally occurring foreign substances or molecules. Cytokines are small proteins that regulate the activities of various cell types in the immune system. The most common symptoms associated with cytokine storms include high fever, diarrhea, weakness, and abdominal pain.
IL Cytokines:
IL cytokines are a group of proteins that are produced in response to interleukin (IL) signals. There are two types of IL cytokines: TNF-related and Interferon-related. The major difference between the two is their signaling pathways; while TNF stimulates nuclear factor ?B, which leads to gene expression, Interferon-? leads to the activation of type I interferons leading to protein synthesis & inhibition of proteases.
Application Insights:
The cancer and malignancy segment dominated the global TNF & IL cytokines market in 2017, accounting for over 40.0% share of the overall revenue. Increasing incidence of cancer is one of the major factors driving this segment. According to WHO, it is estimated that over 1 in 6 people are expected to develop cancer during their lifetime; globally, around 2 million deaths occur due to cancer every year.
TNF-alpha was found most commonly associated with cancers and other diseases such as rheumatoid arthritis and osteoarthritis; however, there have been studies pointing out that both TNF-alpha variants can be associated with different types of cancers (Lundgren et al., 2016). The same holds true for IL-1 beta as well as it has been observed that these two cytokines are involved in various types of cancers (Reddy et al., 2015).
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of key players, favorable government initiatives, and increasing healthcare expenditure are some factors driving the regional market. Asia Pacific is expected to be the fastest-growing region during the forecast period due to rising awareness about available treatment options for chronic diseases and an increase in disposable income levels. Moreover, growing investments by major pharmaceutical companies for R&D activities related to cancer and other inflammatory diseases are also anticipated to drive growth over the forecast period.
The Asia Pacific has one of the highest prevalence rates of chronic illnesses such as cancer & malignancy; arthritis; asthma/airway inflammation; others (CMA) owing to environmental triggers (infectious agents), genetic susceptibility, behavioral factors, etc., which results into high demand for anti-inflammatory drugs that target TNF family members such as adalimumab or etanercept among others).
Growth Factors:
- Increasing prevalence of chronic diseases: The increasing prevalence of chronic diseases such as cancer, autoimmune disorders, and respiratory disorders is expected to drive the demand for TNF & IL Cytokines over the forecast period.
- Growing awareness about cytokine therapies: There is a growing awareness among physicians and patients about the benefits of cytokine therapies, which is expected to boost the demand for TNF & IL Cytokines in the coming years.
- Technological advancements in cytokine therapy: The technological advancements in cytokine therapy are anticipated to fuel the growth of this market during the forecast period. For instance, recently developed recombinant human tumor necrosis factor-alpha (rhTNF-α) has shown better efficacy than other available treatments options for various indications such as rheumatoid arthritis (RA), Crohn’s disease (CD), psoriasis, ankylosing spondylitis (AS), and plaque psoriasis. This will create new opportunities for players operating in this market over the next few years.
- Rising geriatric population: The rising geriatric population is another major factor that is likely to drive growth of this market during the forecast period owing to increased susceptibility of elderly people towards various chronic diseases that require treatment with TNF & IL Cytokines drugs.. According to World Health Organization (WHO), by 2050, there will be more than 2 billion people aged 60 years or above globally which
Scope Of The Report
Report Attributes
Report Details
Report Title
TNF & IL Cytokines Market Research Report
By Type
TNF, IL Cytokines
By Application
Cancer and Malignancy, Arthritis, Asthma / Airway Inflammation, Others
By Companies
AbbVie, Johnson & Johnson, GlaxoSmithKline, Novartis, Roche, Pfizer, Sanofi, Bayer HealthCare Pharmaceuticals, Thermo Fisher Scientific, Biocon, Biotechne, Peprotech, STEMCELL Technologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global TNF & IL Cytokines Market Report Segments:
The global TNF & IL Cytokines market is segmented on the basis of:
Types
TNF, IL Cytokines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer and Malignancy, Arthritis, Asthma / Airway Inflammation, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AbbVie
- Johnson & Johnson
- GlaxoSmithKline
- Novartis
- Roche
- Pfizer
- Sanofi
- Bayer HealthCare Pharmaceuticals
- Thermo Fisher Scientific
- Biocon
- Biotechne
- Peprotech
- STEMCELL Technologies
Highlights of The TNF & IL Cytokines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- TNF
- IL Cytokines
- By Application:
- Cancer and Malignancy
- Arthritis
- Asthma / Airway Inflammation
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the TNF & IL Cytokines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
TNF stands for tumor necrosis factor and IL stands for interleukin. TNF and IL are cytokines, which are proteins that help the body fight infection.
Some of the major companies in the tnf & il cytokines market are AbbVie, Johnson & Johnson, GlaxoSmithKline, Novartis, Roche, Pfizer, Sanofi, Bayer HealthCare Pharmaceuticals, Thermo Fisher Scientific, Biocon, Biotechne, Peprotech, STEMCELL Technologies.
The tnf & il cytokines market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. TNF & IL Cytokines Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. TNF & IL Cytokines Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. TNF & IL Cytokines Market - Supply Chain
4.5. Global TNF & IL Cytokines Market Forecast
4.5.1. TNF & IL Cytokines Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. TNF & IL Cytokines Market Size (000 Units) and Y-o-Y Growth
4.5.3. TNF & IL Cytokines Market Absolute $ Opportunity
5. Global TNF & IL Cytokines Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. TNF & IL Cytokines Market Size and Volume Forecast by Type
5.3.1. TNF
5.3.2. IL Cytokines
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global TNF & IL Cytokines Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. TNF & IL Cytokines Market Size and Volume Forecast by Application
6.3.1. Cancer and Malignancy
6.3.2. Arthritis
6.3.3. Asthma / Airway Inflammation
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global TNF & IL Cytokines Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. TNF & IL Cytokines Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global TNF & IL Cytokines Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. TNF & IL Cytokines Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global TNF & IL Cytokines Demand Share Forecast, 2019-2026
9. North America TNF & IL Cytokines Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America TNF & IL Cytokines Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America TNF & IL Cytokines Market Size and Volume Forecast by Application
9.4.1. Cancer and Malignancy
9.4.2. Arthritis
9.4.3. Asthma / Airway Inflammation
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America TNF & IL Cytokines Market Size and Volume Forecast by Type
9.7.1. TNF
9.7.2. IL Cytokines
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America TNF & IL Cytokines Demand Share Forecast, 2019-2026
10. Latin America TNF & IL Cytokines Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America TNF & IL Cytokines Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America TNF & IL Cytokines Market Size and Volume Forecast by Application
10.4.1. Cancer and Malignancy
10.4.2. Arthritis
10.4.3. Asthma / Airway Inflammation
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America TNF & IL Cytokines Market Size and Volume Forecast by Type
10.7.1. TNF
10.7.2. IL Cytokines
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America TNF & IL Cytokines Demand Share Forecast, 2019-2026
11. Europe TNF & IL Cytokines Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe TNF & IL Cytokines Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe TNF & IL Cytokines Market Size and Volume Forecast by Application
11.4.1. Cancer and Malignancy
11.4.2. Arthritis
11.4.3. Asthma / Airway Inflammation
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe TNF & IL Cytokines Market Size and Volume Forecast by Type
11.7.1. TNF
11.7.2. IL Cytokines
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe TNF & IL Cytokines Demand Share, 2019-2026
12. Asia Pacific TNF & IL Cytokines Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific TNF & IL Cytokines Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific TNF & IL Cytokines Market Size and Volume Forecast by Application
12.4.1. Cancer and Malignancy
12.4.2. Arthritis
12.4.3. Asthma / Airway Inflammation
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific TNF & IL Cytokines Market Size and Volume Forecast by Type
12.7.1. TNF
12.7.2. IL Cytokines
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific TNF & IL Cytokines Demand Share, 2019-2026
13. Middle East & Africa TNF & IL Cytokines Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa TNF & IL Cytokines Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa TNF & IL Cytokines Market Size and Volume Forecast by Application
13.4.1. Cancer and Malignancy
13.4.2. Arthritis
13.4.3. Asthma / Airway Inflammation
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa TNF & IL Cytokines Market Size and Volume Forecast by Type
13.7.1. TNF
13.7.2. IL Cytokines
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa TNF & IL Cytokines Demand Share, 2019-2026
14. Competition Landscape
14.1. Global TNF & IL Cytokines Market: Market Share Analysis
14.2. TNF & IL Cytokines Distributors and Customers
14.3. TNF & IL Cytokines Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AbbVie
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Johnson & Johnson
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. GlaxoSmithKline
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Novartis
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Roche
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pfizer
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sanofi
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bayer HealthCare Pharmaceuticals
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Thermo Fisher Scientific
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Biocon
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Biotechne
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Peprotech
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. STEMCELL Technologies
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
